Henry Ellenbogen
Durable Capital Partners
Henry Ellenbogen Acadia Healthcare Company Inc stake
total: 158
Durable Capital Partners ACHC trades
- Total transactions:
- 11
- New positions:
- 1
- Sold out:
- 1
- Added:
- 6
- Reduced:
- 3
- Held since:
- 2022 Q2
- Held for:
- 10 quarters
- Latest activity:
- 2024 Q4
According to 2026 Q2 report, Henry Ellenbogen doesn't hold any Acadia Healthcare Company Inc (ACHC) shares. To date, the estimated cost basis is nearly $73.61 for "buy" trades and estimated average "sell" price is $67.8. Durable Capital Partners first purchased ACHC in 2022 Q2, initially acquiring 560,841 shares. Since the initial investment in Acadia Healthcare Company Inc (ACHC), Durable Capital Partners has made 10 more transactions.
When did Henry Ellenbogen sell Acadia Healthcare Company Inc (ACHC)?
Henry Ellenbogen sold off the entire Acadia Healthcare Company Inc (ACHC) position in 2024 Q4.
When did Henry Ellenbogen buy Acadia Healthcare Company Inc (ACHC)?
Henry Ellenbogen first invested in Acadia Healthcare Company Inc (ACHC) in 2022 Q2 at the reported quarter-end price of $67.63 per share.
What's the cost basis of Durable Capital Partners's ACHC stake?
The estimated cost basis for Acadia Healthcare Company Inc (ACHC) stake is around $73.61 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $73.61
- Weighted AVG sell price:
- $67.80
Henry Ellenbogen's historical trades in Acadia Healthcare Company Inc
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.00%
|
0
|
$63.41
|
|
-100% (-2,255,059)
|
-1.05%
|
|
2024 Q3
|
1.05%
|
2,255,059
|
$63.41
|
$142,993,291
|
+1.68% (+37,268)
|
+0.02%
|
|
2024 Q2
|
1.23%
|
2,217,791
|
$67.54
|
$149,789,604
|
+58.83% (+821,424)
|
+0.46%
|
|
2024 Q1
|
0.86%
|
1,396,367
|
$79.22
|
$110,620,194
|
-19.44% (-336,936)
|
-0.21%
|
|
2023 Q4
|
1.06%
|
1,733,303
|
$77.76
|
$134,781,641
|
+14.71% (+222,236)
|
+0.14%
|
|
2023 Q3
|
0.97%
|
1,511,067
|
$70.31
|
$106,243,121
|
+8.81% (+122,400)
|
+0.08%
|
|
2023 Q2
|
0.97%
|
1,388,667
|
$79.64
|
$110,593,440
|
-25.98% (-487,441)
|
-0.36%
|
|
2023 Q1
|
1.27%
|
1,876,108
|
$72.25
|
$135,548,803
|
-3.37% (-65,487)
|
-0.05%
|
|
2022 Q4
|
1.66%
|
1,941,595
|
$82.32
|
$159,832,100
|
+30.84% (+457,687)
|
+0.39%
|
|
2022 Q3
|
1.28%
|
1,483,908
|
$78.18
|
$116,012,000
|
+164.59% (+923,067)
|
+0.79%
|
|
2022 Q2
|
0.44%
|
$67.63
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.